- "BioMS/Eli Lilly - Dissecting a Billion Dollar Collaboration" -
Toronto Stock Exchange Symbol: MS
EDMONTON, May 14 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Richard Brown, Vice President, Commercial Development, BioMS Medical and Mr. Jack Tupman, Senior Director, Corporate Business Development, Eli Lilly and Company, will take part in a Technology Transfer/Licensing session at the BIO International Convention 2009 in Atlanta, Georgia entitled "BioMS/Eli Lilly - Dissecting a Billion Dollar Collaboration."
Also participating in the panel session will be Mr. Nitin Kaushal, Director, Healthcare Investment Banking, Desjardins Securities and Mr. Jeremy Webster, Senior VP & Director Deloitte & Touche, LLP. The moderator for the session will be Ms. Cheryl Reicin, Partner, Torys LLP.
WHEN: Thursday May 21st at 8:00am (Eastern Time) WHERE: Room B316, Georgia World Congress Center, Atlanta, Georgia BioMS Medical will also provide a corporate presentation at the Business Forum at 9:40am (Eastern Time) on Wednesday May 20th. About BIO International Convention ---------------------------------- The BIO International Convention, hosted by the Biotechnology Industry Organization, is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. For more information visithttp://convention.bio.org/. About BioMS Medical Corp. -------------------------
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide,
|SOURCE BioMS Medical Corp.|
Copyright©2009 PR Newswire.
All rights reserved